Skip to main content

Windtree Therapeutics Inc

WINT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000946486

No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Windtree Therapeutics Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Windtree Therapeutics Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Windtree Therapeutics Inc
NameTitleLast reported holdingLast filingFilings, past year
Fraser CraigPresident and CEO8,638Oct 9, 20240
Simonson StevenSVP, Chief Medical Officer17,440Jul 24, 20240
Geffken Daniel E.Director2,175Aug 29, 20230
Scott Robert ADirector2,133Aug 25, 20230
Strobeck MarkDirector2,300Aug 25, 20230
Curtis EricSVP & COO15,920Aug 25, 20230
Williams Leslie J.Director2,133Aug 25, 20230
Carman DianeSVP & General Counsel1,227Mar 2, 20230
Huang JamesDirector3,449,161IndirectFeb 23, 20230
Hamill John P.SVP & CFO72,800Jul 26, 20220
Bioengine Capital Inc.10% Owner0Jan 10, 20220
Center Laboratories, Inc.10% Owner1,239,088Jan 10, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 9, 2024 (view filing)Oct 81 dayFraser CraigPresident and CEOPPurchase+5.43K$0.91+$4.94K+169.3%8.64K after
Sep 28, 2023 (view filing)Sep 271 dayFraser CraigPresident and CEOPPurchase+2.50K$1.02+$2.55K+4.5%57.9K after
Sep 27, 2023 (view filing)Sep 261 dayFraser CraigPresident and CEOPPurchase+2.50K$0.90+$2.25K+4.7%55.4K after
Apr 27, 2023 (view filing)Apr 261 dayFraser CraigPresident and CEOPPurchase+1.50K$1.77+$2.65K+27.2%7.01K after
Apr 26, 2023 (view filing)Apr 251 dayFraser CraigPresident and CEOPPurchase+1.31K$1.89+$2.49K+31.3%5.51K after
Jul 27, 2022 (view filing)4:20 PM ETJul 27Same dayFraser CraigPresident and CEOPPurchase+2.50K$0.3799+$949.75+1.1%226.6K after
Jul 26, 2022 (view filing)4:38 PM ETJul 26Same dayHamill John P.SVP & CFOPPurchase+3.00K$0.3666+$1.10K+4.3%72.8K after
Jul 26, 2022 (view filing)4:37 PM ETJul 26Same dayFraser CraigPresident and CEOPPurchase+2.50K$0.374+$935+1.1%224.1K after
Jul 5, 2022 (view filing)4:40 PM ETJun 305 daysFraser CraigPresident and CEOPPurchase+4.50K$0.4279+$1.93K+2.1%221.6K after
Jun 30, 2022 (view filing)6:59 AM ETJun 291 dayFraser CraigPresident and CEOPPurchase+7.00K$0.4154+$2.91K+3.3%217.1K after
Mar 17, 2022 (view filing)Mar 161 dayFraser CraigPresident and CEOPPurchase+2.00K$0.98+$1.96K+1.0%210.1K after
Mar 15, 2022 (view filing)Mar 15Same daySimonson StevenSVP, Chief Medical OfficerPPurchase+5.00K$1.00+$5.00K+6.4%83.6K after
Mar 15, 2022 (view filing)Mar 15Same dayFraser CraigPresident and CEOPPurchase+3.00K$0.98+$2.94K+1.5%208.1K after
Jan 10, 2022 (view filing)May 20, 2020600 daysLateCenter Laboratories, Inc.10% OwnerPPurchase+55.2K$7.25+$400.0K+4.7%1.24M afterDuplicate filing
Jan 10, 2022 (view filing)Dec 30, 202111 daysLateCenter Laboratories, Inc.10% OwnerPPurchase+1.24M$1.60+$1.98MNew position1.24M after
Jan 10, 2022 (view filing)May 20, 2020600 daysLateCenter Laboratories, Inc.10% OwnerPPurchase+55.2K$0.00$0–55.2K afterDerivativeDuplicate filing
Jan 10, 2022 (view filing)May 20, 2020600 daysLateBioengine Capital Inc.10% OwnerPPurchase+55.2K$7.25+$400.0K+4.7%1.24M after
Jan 10, 2022 (view filing)Dec 30, 202111 daysLateBioengine Capital Inc.10% OwnerSSale−1.24M$1.60−$1.98M−100.0%0 after
Jan 10, 2022 (view filing)May 20, 2020600 daysLateBioengine Capital Inc.10% OwnerPPurchase+55.2K$0.00$0–55.2K afterDerivative
Nov 22, 2021 (view filing)Nov 193 daysFraser CraigPresident and CEOPPurchase+930$1.60+$1.49K+2.5%38.2K after
Nov 18, 2021 (view filing)Nov 18Same dayFraser CraigPresident and CEOPPurchase+930$1.61+$1.50K+2.6%37.2K after
Oct 25, 2021 (view filing)Oct 223 daysFraser CraigPresident and CEOPPurchase+3.00K$1.90+$5.70K+9.0%36.3K after
Oct 19, 2021 (view filing)Oct 19Same dayHuang JamesDirectorPPurchase+50.0K$1.90+$95.0K+20.7%291.3K after
Oct 19, 2021 (view filing)Oct 19Same dayFraser CraigPresident and CEOPPurchase+3.00K$1.91+$5.73K+9.9%33.3K after